scholarly journals COVID-19 adenovirus vaccine triggers antibodies against PF4 complexes to activate complement and platelets

2021 ◽  
Author(s):  
Hanna H. Pitkänen ◽  
Annukka Jouppila ◽  
Tuukka Helin ◽  
Vinaya Dulipati ◽  
Juha Kotimaa ◽  
...  
Keyword(s):  
Adenovirus Vaccine

Adenovirus vaccine

Vaccines ◽  
2008 ◽  
pp. 1103-1122 ◽  
Author(s):  
Charlotte A. Gaydos ◽  
Gregory C. Gray
Keyword(s):  
Adenovirus Vaccine

Adjuvant Influenza Adenovirus Vaccine

JAMA ◽  
1962 ◽  
Vol 179 (8) ◽  
pp. 594 ◽  
Author(s):  
Gordon Meiklejohn
Keyword(s):  
Adenovirus Vaccine

A combined bovine parainfluenza and adenovirus vaccine

1969 ◽  
Vol 84 (12) ◽  
pp. 299-303 ◽  
Author(s):  
G. Tribe ◽  
A. Kanarek ◽  
J. Kerry ◽  
G. White
Keyword(s):  
Adenovirus Vaccine

scholarly journals An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates

2016 ◽  
Vol 214 (suppl 3) ◽  
pp. S326-S332 ◽  
Author(s):  
Shipo Wu ◽  
Andrea Kroeker ◽  
Gary Wong ◽  
Shihua He ◽  
Lihua Hou ◽  
...  
Keyword(s):  
Guinea Pigs ◽  
Nonhuman Primates ◽  
Ebola Virus ◽  
Virus Variant ◽  
Adenovirus Vaccine

scholarly journals Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41

Vaccine ◽  
2007 ◽  
Vol 25 (11) ◽  
pp. 2074-2084 ◽  
Author(s):  
Franck Lemiale ◽  
Hedi Haddada ◽  
Gary J. Nabel ◽  
Douglas E. Brough ◽  
C. Richter King ◽  
...  
Keyword(s):  
Vaccine Vectors ◽  
Adenovirus Vaccine

scholarly journals Adenovirus Type 4 and 7 Vaccination or Adenovirus Type 4 Respiratory Infection Elicits Minimal Cross-Reactive Antibody Responses to Nonhuman Adenovirus Vaccine Vectors

2014 ◽  
Vol 21 (5) ◽  
pp. 783-786 ◽  
Author(s):  
Robert Paris ◽  
Robert A. Kuschner ◽  
Leonard Binn ◽  
Stephen J. Thomas ◽  
Stefano Colloca ◽  
...  
Keyword(s):  
Respiratory Infection ◽  
Neutralizing Antibodies ◽  
Adenovirus Vector ◽  
Adenovirus Type ◽  
Cross Reactivity ◽  
Antibody Responses ◽  
Vaccine Vectors ◽  
Adenovirus Vaccine ◽  
Reactive Antibody

ABSTRACTAntivector immunity may limit the immunogenicity of adenovirus vector vaccines. We tested sera from individuals immunized with adenovirus type 4 and 7 (Ad4 and Ad7, respectively) vaccine or naturally infected with Ad4 for their ability to neutralize a panel of E1-deleted human and chimpanzee adenoviruses (ChAd). Small statistically significant increases in titers to ChAd63, ChAd3, human Ad35, and human Ad5 were observed. Neutralizing antibodies elicited by Ad4 infection or immunization results in a small amount of adenovirus cross-reactivity.

EVALUATION OF AN ADENOVIRUS VACCINE IN A DISPENSARY POPULATION1

1960 ◽  
Vol 72 (1) ◽  
pp. 100-110
Author(s):  
REUEL A. STALLONES ◽  
EDWIN H. LENNETTE ◽  
ROBERT E. NITZ ◽  
ALFONSO H. HOLGUIN
Keyword(s):  
Adenovirus Vaccine
Sign in / Sign up

Export Citation Format

Share Document